Keywords: fujisawa, outlines, strategic, restructuring, interview, marketletter, pharmaceutical

Fujisawa outlines strategic restructuring in interview with Marketletter

Article | 23 June 2003

Print This

Fujisawa Pharmaceutical, the fifth largest drug firm in Japan and intent on expanding its overseas operations building on its tacrolimus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in